Medicare Enrolled
Dr. Mohamed Shahed, MD
Internal Medicine · Fairview Park, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shahed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shahed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shahed
Dr. Mohamed Shahed is an internal medicine specialist in Fairview Park, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Shahed performed 1,541 Medicare services across 1,040 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shahed received a total of $10,018 from 56 pharmaceutical and/or device companies across 715 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shahed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in OH
$10,018 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,541
Medicare services
Top 14% in OH for internal medicine
1,040
Unique beneficiaries
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
417 | $43 | $190 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
237 | $11 | $126 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
187 | $25 | $171 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
180 | $86 | $156 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
112 | $54 | $265 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
84 | $43 | $65 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
56 | $127 | $303 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
53 | $88 | $160 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
37 | $1 | $20 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
34 | $32 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $19 | $130 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
30 | $73 | $340 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
27 | $29 | $30 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
25 | $44 | $102 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $94 | $242 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
14 | $44 | $240 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
0.0% medium
96.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,018
Total received (2018-2024)
Avg $1,431/year across 7 years
Top 8% in OH for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
715
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,018 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$618
2023
$1,880
2022
$2,352
2021
$1,424
2020
$612
2019
$1,468
2018
$1,665
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$217
Novo Nordisk Inc
$151
Lilly USA, LLC
$49
Xeris Pharmaceuticals, Inc.
$47
Amgen Inc.
$36
IRONWOOD PHARMACEUTICALS, INC
$22
E.R. Squibb & Sons, L.L.C.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
Dexcom, Inc.
$15
Corcept Therapeutics
$14
Exact Sciences Corporation
$14
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,687
AbbVie Inc.
$1,286
ABBVIE INC.
$1,124
AstraZeneca Pharmaceuticals LP
$923
Lilly USA, LLC
$562
Amgen Inc.
$393
Bayer HealthCare Pharmaceuticals Inc.
$284
PFIZER INC.
$245
E.R. Squibb & Sons, L.L.C.
$244
Takeda Pharmaceuticals U.S.A., Inc.
$223
Boehringer Ingelheim Pharmaceuticals, Inc.
$215
Smith+Nephew, Inc.
$181
GlaxoSmithKline, LLC.
$170
BOSTON SCIENTIFIC CORPORATION
$159
Osiris Therapeutics Inc.
$138
Novartis Pharmaceuticals Corporation
$129
Astellas Pharma US Inc
$120
SANOFI-AVENTIS U.S. LLC
$120
Merck Sharp & Dohme Corporation
$119
Merck Sharp & Dohme LLC
$116
Sunovion Pharmaceuticals Inc.
$111
Xeris Pharmaceuticals, Inc.
$105
Melinta Therapeutics, Inc.
$74
Stryker Corporation
$72
AbbVie, Inc.
$69
Mannkind Corporation
$69
IDORSIA PHARMACEUTICALS US INC
$67
Janssen Pharmaceuticals, Inc
$66
Ironwood Pharmaceuticals, Inc
$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$62
Allergan Inc.
$61
Corium, LLC
$59
Dexcom, Inc.
$54
Biohaven Pharmaceutical Holding Company Ltd.
$49
Ultragenyx Pharmaceutical Inc.
$48
Eisai Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$42
Misonix Inc
$41
Lundbeck LLC
$41
Circassia Pharmaceuticals Inc
$36
Boston Scientific Corporation
$35
Neurocrine Biosciences, Inc.
$29
Supernus Pharmaceuticals, Inc.
$28
Kowa Pharmaceuticals America, Inc.
$26
Relypsa, Inc.
$25
Medtronic, Inc.
$25
Biohaven Pharmaceuticals, Inc.
$23
Allergan, Inc.
$23
IRONWOOD PHARMACEUTICALS, INC
$22
Scilex Pharmaceuticals Inc.
$21
Hikma Pharmaceuticals USA
$16
Avanir Pharmaceuticals, Inc.
$15
Corcept Therapeutics
$14
Exact Sciences Corporation
$14
MannKind Corporation
$14
Smith & Nephew, Inc.
$13
Top 3 companies account for 40.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AREXVY · Aduhelm · Aimovig · Amitiza · Azstarys · BAQSIMI · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · BYDUREON · Baxdela · CHANTIX · CREON · Cologuard Collection Kit · Crysvita · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Entyvio · FARXIGA · FORTEO · GENERAL VASCULAR INTERVENTION · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · GVOKE HYPOPEN · GVOKE PFS · General - Balloons · Grafix PL PRIME · INGREZZA · INTERSTIM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LINZESS · LOKELMA · LONHALA MAGNAIR · LYRICA · Leqembi · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · NUEDEXTA · NURTEC ODT · Ongentys · Otezla · Ozempic · PAXLOVID · PRADAXA · Prolia · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SEEBRI · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · STAR · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Santyl · Saxenda · Stravix · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TUDORZA PRESSAIR · Tresiba · Trintellix · UBRELVY · VERQUVO · VIBERZI · VRAYLAR · VYVANSE · Veltassa · Veozah · Victoza · WATCHMAN · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for internal medicine in OH.
Geographic Context
Internal medicine physicians within 10 mi
1,149
Per 100K population
92.0
County median income
$62,823
Nearest hospital
FAIRVIEW HOSPITAL
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shahed is a clinical cardiology specialist, with above-average Medicare volume (top 14% in OH), with low-engagement industry engagement in the top 8% of OH peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shahed experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Shahed performed 417 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shahed receive payments from pharmaceutical companies?
Yes. Dr. Shahed received a total of $10,018 from 56 companies across 715 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shahed's costs compare to other internal medicine physicians in Fairview Park?
Dr. Shahed's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shahed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Fairview Park
Browse internal medicine physicians in Fairview Park ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in OH
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in OH
Which OH internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology